Skip to content
Steady
Join waitlist
ResearchSide effects
Side effectsHairNutrition

Hair shedding on Ozempic: why it happens at month three, and what actually helps

Telogen effluvium is the medical name. Rapid weight loss is the trigger. Protein, iron, and patience are most of the answer.

Published April 19, 20266 min read

The 30-second summary

  • The shedding most GLP-1 users see at month 3–6 is telogen effluvium — a temporary shift caused by rapid weight loss, not the medication's pharmacology.
  • Adequate protein (typically 100–120 g/day for most women), iron, ferritin, vitamin D, and zinc are the targets that actually matter.
  • Shedding usually resolves within 3–6 months of the trigger ending. Biotin supplements do essentially nothing, and can interfere with lab tests.

What you are looking at in the shower

You started on a GLP-1 in January. February was nausea. March was "wait, this is working." And then one morning in May, the drain caught a wad of hair that made you stop breathing for a second.

It is a specific, unforgettable moment, and almost every woman on a GLP-1 long enough has a version of it.

It is almost always telogen effluvium: a temporary, generalized shedding caused by the body reacting to a "stressor" — in this case, rapid weight loss and a sharp drop in caloric intake. It looks catastrophic because you notice it all at once, but the physiology is straightforward.

The biology, quickly

At any given time, roughly 85–90% of your scalp hair is in the growth (anagen) phase and 10–15% is in the resting (telogen) phase. Each hair stays in anagen for years before transitioning to a brief telogen and shedding to make room for the next one. On a normal day, you lose 50–100 hairs.

When the body experiences a meaningful stressor — childbirth, severe illness, surgery, rapid weight loss, abrupt caloric restriction — a larger-than-usual fraction of hair follicles are pushed into the telogen phase at roughly the same time. They sit there for two to three months. And then, in a window of weeks, they all shed at once.

That two- to three-month delay is why GLP-1 users usually notice shedding at month three to six, even if the weight loss started much earlier. By the time you see it in the drain, the event that triggered it is already a month or two behind you.

Is it the Ozempic itself?

Not directly, no. The prescribing information for semaglutide (Wegovy) does list alopecia as an adverse event — roughly 3% in the STEP 1 trial versus 1% in placebo — but the mechanism in every large review is rapid weight loss rather than a direct follicular effect of the drug. Tirzepatide shows a similar pattern.

This matters because it changes what you do about it. If the shedding is a consequence of aggressive weight loss, then the answer is not to stop the medication — it is to make sure the loss is happening with adequate nutrition, and to give the hair cycle time to reset.

What actually helps

The evidence base for "hair interventions" is famously noisy. Stripping away the noise, these are the inputs that matter.

Protein. Hair is keratin — a structural protein. In a caloric and protein deficit, your body does not prioritize hair; it prioritizes organs. Most dietitians working with GLP-1 patients are targeting 1.2 to 1.6 g/kg of goal body weight per day. For a woman whose goal weight is 75 kg, that is 90–120 g/day. See our protein article for the detail.

Iron and ferritin. Iron deficiency — even subclinical — is a well-documented contributor to telogen effluvium in women. Ferritin (a storage form of iron) under 30 ng/mL is associated with increased shedding in multiple studies. Some dermatologists recommend a target of 50 ng/mL or higher for women with active shedding. Ask your prescriber for a ferritin test; do not supplement iron without one.

Vitamin D. Low vitamin D is common, especially in winter and in regions with limited sun, and is associated with hair-cycle disruption. Testing is cheap and worthwhile.

Zinc. Deficiency is associated with shedding; supplementation beyond deficiency does not help and can cause its own problems. Again: test before supplementing.

Calories. A caloric deficit of more than ~750 kcal/day sustained over months is correlated with more shedding. For most GLP-1 users, the accidental deficit is larger than intended — appetite is so suppressed that intake drops below what the body actually needs. Not eating enough is often the fixable part.

Sleep and stress. Neither causes telogen effluvium on its own, but both compound it. GLP-1 users often report poorer sleep early in treatment; this usually resolves by month three but is worth naming.

What doesn't help (and what might hurt)

Biotin. Widely recommended, almost useless for telogen effluvium in adults without true biotin deficiency. Worse, biotin supplementation can interfere with certain common lab tests (thyroid function, troponin) and produce misleading results. If you are already taking it, stop at least three days before any blood test.

Generic "hair vitamins." Most are biotin + marketing. If you have tested and are deficient in a specific nutrient, correct that specific deficiency.

Minoxidil. Effective for androgenetic alopecia (pattern hair loss), not the target mechanism for telogen effluvium. Dermatologists sometimes add it for patients with overlapping patterns; it is not a first-line response to the kind of shedding triggered by rapid weight loss.

Panicking and stopping the GLP-1. Discuss with your prescriber before any dose change. In most cases the recommendation is to adjust nutrition and let the hair cycle complete — not to reverse the weight loss that is otherwise benefiting you.

When to see a dermatologist

The typical telogen effluvium after rapid weight loss is diffuse, temporary, and self-resolving. There are patterns that do not fit that description and deserve a specialist's eye:

  • Shedding that is patchy or localized to one area of the scalp (could be alopecia areata)
  • A receding hairline or widening part that predates the GLP-1 (could be androgenetic alopecia, often runs in families)
  • Shedding that continues for more than 9–12 months with no improvement
  • Scalp pain, burning, or scarring
  • Significant hair loss on eyebrows, eyelashes, or body hair as well

A dermatologist can do a "pull test" and, if warranted, a scalp biopsy. Both are quick, cheap, and informative.

The timeline most people want to hear

For a typical telogen effluvium triggered by rapid weight loss on a GLP-1:

  • Trigger event: the first 8–12 weeks of rapid loss
  • Visible shedding: begins 2–4 months after the trigger, peaks around month 4–6
  • Shedding slows: 6–9 months after it started, assuming the nutritional inputs are in place
  • Full regrowth: 12–18 months from the start of shedding, because new hairs grow roughly 1 cm per month

The hair is almost always growing back while it is still shedding; it is just shorter than the surrounding hairs. Many women notice a "halo" of new baby hairs along the hairline in month 6–9 — that is the regrowth, right on schedule.

How to use this practically

Shedding is rarely a standalone problem. It tends to travel with protein shortfalls, aggressive calorie deficits, and the first few months of rapid loss. If you are tracking your protein, your weight trend, and the month you are on in your GLP-1 journey, you already have most of the pattern you need.

The useful things to bring to your prescriber are not "my hair is falling out" but "my hair started shedding in month four of tirzepatide, my protein has averaged 85 g, and I would like to check ferritin, vitamin D, and TSH." That conversation is short and productive. The one without the numbers usually isn't.

What we will not do, in this article or in Steady, is tell you the shedding isn't happening. It is. What we'll tell you is what the path out looks like, and how long it takes.

Sources

  1. Harrison S, Bergfeld W. Diffuse hair loss: its triggers and management. Cleve Clin J Med 2009. PubMed
  2. Malkud S. Telogen Effluvium: A Review. J Clin Diagn Res 2015. PubMed
  3. Trüeb RM. Nutritional deficiency and hair loss. Dermatol Pract Concept 2019. PubMed
  4. Kantor J, Kessler LJ, Brooks DG, Cotsarelis G. Decreased serum ferritin is associated with alopecia in women. J Invest Dermatol 2003. PubMed
  5. Wegovy (semaglutide) Prescribing Information — adverse events. FDA label

Medical disclaimer: This article is educational, not medical advice. Persistent shedding, patterned hair loss, or any associated scalp symptom should be evaluated by a dermatologist. Do not start or stop supplements without your prescriber's input. See our full medical disclaimer.

Reviewed by Steady editorial team.
Last updated 2026-04-19.
Keep reading